(S)-(4-溴-2-甲苯)(3-甲基吗啉)甲酮的合成

以(S)-2-氨基丙醇和氯乙酰氯为起始原料,经酰化和环合反应制得(S)-5-甲基吗啉-3-酮（4）; 4经还原制得(S)-3-甲基吗啉(5); 5与4-溴-2-甲基苯甲酸酰化缩合合成了(S)-(4-溴2-甲基苯基)(3-甲基吗啉)-甲酮,总收率57%,其结构经¹H NMR 和 ¹³C NMR确证。     

AZD0914关键中间体(2R,6R)-2,6-二甲基吗啉的合成工艺研究

(2R,6R)-2,6-二甲基吗啉(1)为合成新型细菌II型拓扑异构酶抑制剂AZD0194(Zoliflodacin)的关键中间体。本文以(S)-2-羟基丙酸乙酯(12)为原料,经三氟甲磺酰化、S_N2反应、硼氢化钠还原、对甲苯磺酰化、环合、成盐、催化氢解、游离和蒸馏提纯等步骤,成功合成了化合物1。经过对合成路线中反应条件及提纯方法的优化,以6步反应且总收率为32%获得化合物1。     

(5S,6R)-2-(4-甲基)苯基-6-[(1R)-叔丁基二甲基硅氧乙基]-青霉烯-3-羧酸乙酯的合成研究

青霉烯[1]类抗生素是近年来发展很快的一种非典型β-内酰胺抗生素.青霉烯类化合物[2]具有广泛的抗菌活性,具有优于碳青霉烯类抗生素的特点,其固体化合物和酯型前药可口服吸收,不易被β-内酰胺酶水解,同时对脱氢肽水解酶-I( DHP-I )较碳青霉烯稳定.     

吗啉-2,5-二酮衍生物及其聚合物的研究进展

吗啉-2,5-二酮衍生物是一类制备可生物降解材料的环状单体,本文综述了吗啉-2,5-二酮衍生物及其聚合物的合成方法,以及其在生物医用领域的应用前景。首先介绍了吗啉-2,5-二酮衍生物的三种合成方法,以及采用吗啉-2,5-二酮衍生物均聚反应制备聚缩肽的方法,其次介绍了吗啉-2,5-二酮衍生物与ε-己内酯和丙交酯开环共聚制备基于氨基酸的共聚物。最后,总结了吗啉-2,5-二酮衍生物嵌段共聚物的制备,及其在药物释放和基因载体应用研究中的最新进展。     

由(S)-和( R )-天冬氨酸合成( R )-和(S)-(2-苄氧乙基)环氧乙烷的改良方法

苄氧乙基环氧乙烷;不对称合成;由(S)-和( R )-天冬氨酸合成( R )-和(S)-(2-苄氧乙基)环氧乙烷的改良方法     

(3S,4S)-4-氨基-3-羟基-6-甲基庚酸的合成

价廉易得的L-亮氨酸先以苄基同时保护氨基及羧基得(S)-2-(二苄胺基)-4-甲基戊酸苄酯,进而在碱性条件下与乙腈发生亲核取代反应得(S)-4-(二苄胺基)-6-甲基-3-氧代庚腈,再经硼氢化钠选择性还原羰基得(3S,4S)-4-(二苄胺基)-3-羟基-6-甲基庚腈,用双氧水氧化得(3S,4S)-4-(二苄胺基)-3-羟基-6-甲基庚酸,最后在Pd(OH)2/C-H2作用下脱掉苄基得到(3S,4S)-4-氨基-3-羟基-6-甲基庚酸,即(3S,4S)-statine。整个合成路线总产率为33.6%。     

(S)-3-(3,4-二甲氧基苯基)-2-甲基丙氨酸衍生的手性咪唑啉酮催化剂合成新方法

以(S)-3-(3,4-二甲氧基苯基)-2-甲基丙氨酸盐酸盐为原料,针对其合成咪唑啉酮催化剂过程中反应条件苛刻和反应时间长等问题,重新设计了一条合成路线,并考察了温度、原料摩尔比和反应时间等对合成收率的影响。新合成路线中,合成关键中间体(S)-3-(3,4-二甲氧基苯基)-2-甲基丙氨酸甲酰胺7的反应时间由9 d缩短至7 h,不需剧毒的NaCN催化,收率达到98%。     

(3S)-2,2-二甲基-3-苄氧基癸酸的合成

以 (R) pantolactone为原料 ,经还原、羟基保护、环合、开环、脱保护、氧化等 8步反应 ,合成了 (3S) 2 ,2 二甲基 3 苄氧基癸酸 ,总收率为 40 0 % .     

光学纯(S)-2-(苄氧酰氨基)-4-氧代丁酸苄酯的合成和结构表征

以L-蛋氨酸为起始原料,经甲基化、水解、羧基和氨基保护及氯铬酸吡啶嗡盐(PCC)氧化等6步反应,合成了高光学纯度的(S)-2-(苄氧酰氨基)-4-氧代丁酸苄酯。通过1HNMR、IR、MS和mp测试技术表征了其结构;分别用手性柱HPLC和旋光仪法测定了它的化学纯度和光学纯度(ee%值)分别为99.3%和99.5%,产物的总收率为30.0%。     

铅(Ⅱ)与三(2-(6-甲基吡啶基)甲基)胺配合物的合成及晶体结构的研究

本文合成了标题配合物［Pb(TLA)·NO₃］·NO₃(TLA=三(2-(6-甲基吡啶基)甲基)胺，对其红外光谱及晶体结构进行了研究。结果表明，晶体属单斜晶系，P2₁/n空间群，晶胞参数如下：a=10.234(2)?，b=15.347(3)?，c=15.395(3)?，β=99.93(2)°，V=2382(2)?³，Z=4     

Synthesis of (4R)-Methylnonan-1-ol and (4R,8RS)-Dimethyldecanal from (S)-(+)-3,7-Dimethyl-1,6-octadiene

Optically active (4R,8RS)-dimethyldecanal, an analog of the aggregation pheromone of the flour beetles Tribolium confusum and T. Castaneum, and (4R)-methylnonan-1-ol, the sex pheromone of the yellow mealworm Tenebrio molitor L., are synthesized using ozonolytic transformation of (6R,10)-dimethyl-9-undecen-2-one to (6R)-methyl-9-hydroxynonan-2-one in the key step. The starting compound is available as enantiomerically enriched (ee ~50%) (S)-(+)-3,7-dimethyl-1,6-octadiene.     

Crystal Structure and Biological Activities of (R)-N''-[2-(4-Methoxy-6-chloro)-pyrimidinyl]-N-[3-methyl-2-(4-chlorophenyl)butyryl]-urea

The title compound (R)-N'-[2-(4-methoxy-6-chloro)-pyrimidyl]-N-[3-methyl-2-(4-chlorophenyl)butyryl]-urea has been synthesized, and its crystal structure and biological behaviors were studied. Crystallographic data: C17H18Cl2N4O3, Mr = 397.25, monoclinic, space group P21/c, a = 12.331 (2), b = 14.025(3), c = 23.085(5) (A), β = 99.607(4)°, Z = 8, V = 3936.2(13) (A)3, Dc = 1.341 g/cm3, F(000) = 1648, R = 0.0718, wR = 0.1585 and μ(MoKα) = 0.353 mm-1. The preliminary biological tests showed that the title compound has definite insecticidal and fungicidal activities.     

Synthesis and Crystal Structure of N-[(3aR,4R,4aR,5aS,6S,6aS)-1,3-Dioxooctahydro-4,6-ethenocyclopropa[f]lisoindol-2(1H)-yl]-3-(trifluoromethyl)phenylmethanimine

The crystal structure of the title compound (C19H15F3N2O2, Mr= 360.33) was determined by single-crystal X-ray diffraction. The crystal belongs to triclinic, space group P(1), with a = 6.5604(7), b = 13.9614(16), c = 18.1790(18) (A), α = 102.749(7),β = 97.542(6), γ = 94.355(4)°, V= 1600.5(3) (A)3, Z = 4, Dc = 1.495 g/cm3, λ(MoKα) = 0.71070, F(000) = 744, μ(MoKα) = 0.122mm-1, R = 0.0434 and wR = 0.1051. A total of 7590 unique reflections were collected, of which 5429 with |F|2 ≥ 2σ|F|2 were observed. The two cyclohexene rings in the molecule adopt boat-boat conformations with the deviations of ring atoms C(9) and C10 from the C(5)/C(6)/C(7)/C(8) plane (Ⅰ) by 1.1204 (0.0023) and 1.1132 (0.0023) (A), respectively, whereas from the C(2)/C(3)/C(5)/C(8)plane (Ⅱ) by 1.1627 (0.0022) and 1.1818 (0.0021) (A), respectively. In the cyclopropane and lactam rings, atoms C(11) and N(1) point towards the double bond of C(9)-C(10) and the dihedral angle between the ring plane (Ⅲ) containing C(1), C(2), C(3) and C(4) and plane (Ⅳ) consisting of C(6),C(7) and C(11) is 55.76 (0.07)°. The dihedral angles between planes Ⅳ and Ⅰ and Ⅱ and Ⅲ are 63.58 (0.07)° and 58.10 (0.06)°, respectively. The dihedral angle between the benzene ring C(13)～C(18) and plane Ⅳ is 42.41 (0.06)°.     

(+)-(1S,2S,5R)-8-联苯薄荷醇的合成

以(R)-( )-pu legone为起始原料,经1,4-加成,还原两步反应合成了手性辅助试剂( )-(1S,2S,5R)-8-联苯薄荷醇及其差向异构体(-)-(1R,2S,5R)-8-联苯薄荷醇,总产率95%。其结构经1H NMR,13C NMR,IR,MS和X-射线衍射仪表征。     

Synthesis,Crystal Structure and Antitumor Activity of 2-(3-Methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione

The title compound 2-(3-methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione(C12H10N4O2S, Mr = 274.30) has been synthesized by a three-step procedure including the cyclization, hydrazinolysis and substitution reactions, and its crystal structure was determined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P21/c with a = 12.264(3), b = 14.646(3), c = 14.349(4) , β = 91.69(3)°, μ = 0.255 mm-1, Mr = 274.30, V = 2576.2(10) 3, Z = 8, Dc = 1.414 g/cm3, F(000) = 1136, R = 0.0487 and w R = 0.1329 for 4048 observed reflections with Ⅰ 2σ(Ⅰ). In addition, the preliminary bioassay suggested that the title compound 6 exhibits relatively good antitumor activity against HT-29 and MCF-7.     

Syntheses and Crystal Structures of Ca3Fe2(SeO3)6 and Sr3Fe2(SeO3)6

The new compounds M₃Fe₂(SeO₃)₆ (M = Ca, Sr) were obtained as crystalline precipitates from aqueous solutions of the respective ions, kept in Teflon-coated vessels at a temperature of 227(2)°C for several days. The crystal data are: space group R3 c, a = 8.531(2), 8.802(2) Å; c = 38.89(1), 39.00(1) Å; V = 2451.1, 2616.7 ų, Z = 6. The crystal structures have been refined by single-crystal X-ray diffraction methods to R1 = 0.021, 0.023; wR2 = 0.038, 0.039. The framework structure is built up by two types of FeO₆ octahedra as well as by MO₈ groups and SeO₃ trigonal pyramids by corner- and edge-linkage of the polyhedra.     

Asymmetric Synthesis of (R)-and (S)-Moprolol

A simple and effective procedure for the enantioselective synthesis of (R)-and (S)-moprolol was described.The key step was the asymmetric synthesis of enantiopure (R)-and (S)-guaifenesin,which were synthesized from enantioenriched (R)-3-chloro-1,2-propanediol and (S)-epichlorohydrin via kinetics of hydrolysis resolution of racemic epichlorohydrin by chiral Salen-CoIIII complex.The e.e.values of both the optical compounds were above 98%,and the chemical structures of the target compounds were confirmed by 1H NMR,13C NMR,IR,and MS.     

新型手性N-烷基-3-蒎胺类化合物的合成及其抑菌活性的研究

以(1S,5S)-(－)-α-蒎烯为原料合成了系列新型(1S,2S,3S,5R)-N-烷基-3-蒎胺类化合物. (－)-α-蒎烯经硼氢化氧化、重铬酸吡啶盐(PDC)氧化得到(1S,2S,5R)-(－)-3-蒎酮; 在BF3•(C2H5)2O催化下(1S,2S,5R)-(－)-3-蒎酮与伯胺化合物反应生成Schiff碱, 再经KBH4或NaBH4还原得到(1S,2S,3S,5R)-N-烷基-3-蒎胺类化合物. 采用FT-IR, 1H NMR, 13C NMR和GC-MS等分析手段对合成所得(1S,2S,5R)-N-烷基-3-蒎烷亚胺和(1S,2S,3S,5R)-N-烷基-3-蒎胺类化合物的结构进行了表征. 考察了(1S,2S,3S,5R)-N-烷基-3-蒎胺类化合物对大肠杆菌(E. coli)、金黄色葡萄球菌(S. aureus)、枯草芽胞杆菌(B. subtilis)、荧光假单胞菌(P. fluorescens)、白色念珠菌(C. albicans)、黑曲霉(A. niger)和米根霉(R. oryzae)等细菌和真菌的抑菌和杀菌活性. 结果表明(1S,2S,3S,5R)-N-正庚基-3-蒎胺对真菌和细菌均表现出良好的杀菌和抑菌活性.     

离子液体中脂肪酶催化拆分外消旋烯丙酮醇反应

 以离子液体为溶剂,考察了溶剂类型、水活度、温度、 pH值和共溶剂等因素对脂肪酶催化拆分外消旋烯丙酮醇(R,S)-4-羟基-3-甲基-2-(2-丙烯基)-2-环戊烯-1-酮反应的影响,并与常用于外消旋烯丙酮醇拆分的有机溶剂乙酸乙烯酯进行了比较. 结果表明,在离子液体［bmim］PF6中脂肪酶的催化性能较好,酶初始反应速率为18.48 μmol/(g·min), 半衰期为74.53 h, 高于在乙酸乙烯酯中的相应值(9.18 μmol/(g·min)和64.29 h). 但离子液体中拆分反应的转化率低于在乙酸乙烯酯中的转化率,可以通过向离子液体中补加酰基供体来提高外消旋烯丙酮醇的转化率. 两种反应介质中最佳酶反应条件均为水活度0.17, 温度40 ℃和pH=7, 但加入共溶剂后,离子液体中脂肪酶催化拆分外消旋烯丙酮醇的效率降低,而在乙酸乙烯酯中则有所提高.     

含(R)或(S)-1,1''''-联萘和噁二唑单元的手性高分子合成与性质研究

在Pd(PPh3)4催化下, 将单体(S)-6,6'-二溴-2,2'-二正丁氧基-1,1'-联萘[(S)-M-1]和(R)-6,6'-二溴-2,2'-二正丁氧基-1,1'-联萘[(R)-M-1]分别与2,5-二(4-三正丁基锡基苯)-1,3,4-噁二唑(M-2)通过Stille交叉耦合反应合成了手性高分子P-1与P-2, 并用 1H NMR、 13C NMR、 FTIR、 UV、热分析、荧光光谱、 GPC和CD等分析方法进行了表征. 手性高分子P-1和P-2都能发射较强的蓝色荧光; 在高分子侧链上引入丁氧基后使得手性高分子的溶解性能增强, 并具有良好的成膜性能; 在高分子主链引入亲电子的噁二唑生色团能使其特别适合于作为空穴电子传输层, 对氧和热特别稳定, 是一类潜在的光电高分子材料.